v3.10.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2018
Mar. 31, 2018
Current assets    
Cash $ 6,122,902 $ 6,974,070
Accounts receivable 74,813 74,813
Prepaid expenses and other current assets 143,620 181,367
Total current assets 6,341,335 7,230,250
Property and equipment, net 21,734 27,552
Patents, net 73,541 75,832
Deposits 17,131 18,270
Total assets 6,453,741 7,351,904
Current liabilties    
Accounts payable 143,102 124,450
Due to related parties 90,366 90,366
Other current liabilities 237,990 263,141
Total current liabilities 471,458 477,957
Convertible notes payable, net 871,440 841,153
Total liabilities 1,342,898 1,319,110
Stockholders' Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized as of June 30, 2018 and March 31, 2018; 17,761,206 and 17,739,511 shares issued and outstanding as of June 30, 2018 and March 31, 2018, respectively 17,762 17,740
Additional paid-in capital 105,804,417 105,574,014
Accumulated deficit (100,603,942) (99,457,714)
Total Aethlon Medical, Inc. stockholders' equity before noncontrolling interests 5,218,237 6,134,040
Noncontrolling interests (107,394) (101,246)
Total stockholders' equity 5,110,843 6,032,794
Total liabilities and stockholders' equity $ 6,453,741 $ 7,351,904

Source